What Is a Normal GFR for a 70-Year-Old?

A GFR (glomerular filtration rate) in the range of roughly 60 to 90 mL/min/1.73 m² is common among healthy 70-year-olds, but those numbers come with a significant caveat: kidneys lose filtering capacity as part of normal aging, and many people at 70 fall below the textbook “normal” of 90 or higher without having kidney disease. Among carefully screened healthy kidney donors, GFR declines at a rate of about 6 mL/min per decade, which means a person who started at 120 in their twenties could land in the mid-60s by their seventies and still have perfectly functional kidneys. The real question isn’t whether a particular number looks alarming on a lab report, but whether the kidneys behind that number are declining at a worrying pace.

Why GFR Drops With Age

Your kidneys contain roughly a million tiny filtering units called nephrons, and over a lifetime, a portion of them scar and stop working. The walls of the small arteries feeding the kidneys thicken and stiffen, blood flow to the kidneys drops, and the proportion of scarred-out glomeruli (the individual filters inside each nephron) climbs. At the same time, the surviving nephrons enlarge somewhat to compensate, but they can’t fully make up the difference.

Studies of healthy kidney donors confirm that GFR falls by about 6.3 mL/min/1.73 m² per decade on average, though there is wide person-to-person variability in how fast this happens.1PubMed Central. Structural and Functional Changes With the Aging Kidney Some people reach their eighties with a GFR still in the 70s; others dip into the 50s while remaining healthy by every other measure.2PubMed Central. The aging kidney: physiological changes The underlying structural changes, including thickening of arterial walls and scarring between the kidney tubules, are so consistent across aging populations that pathologists sometimes call them “nephrosclerosis” even in the absence of disease.3PubMed Central. A framework of biomarkers for renal aging: a consensus statement by the Aging Biomarker Consortium

The Problem With the 60 mL/min Cutoff

In standard medical guidelines, an estimated GFR (eGFR) below 60 mL/min/1.73 m² that persists for three months or more qualifies as Stage 3 chronic kidney disease (CKD). For a 40-year-old, that cutoff makes sense: a GFR in the 50s at that age signals something beyond normal aging. For a 70-year-old, the picture is murkier. One large study modeled average eGFR by age and sex and found that the mean eGFR for men by their late seventies and women by about 78 was already below 60.4PubMed Central. Chronic Kidney Disease Age and the Course of GFR in Persons Aged 70 and Above In other words, a fixed threshold of 60 labels a large share of elderly adults as having kidney disease when many of them are simply aging normally.

This has triggered an ongoing debate in nephrology. A study published in JAMA Internal Medicine examined older adults whose eGFR fell between 45 and 59 with normal or near-normal levels of protein in their urine. Among these people, three-quarters of whom were 65 or older, the five-year risk of kidney failure was extremely low, about 0.12% or less, which was comparable to people whose eGFR was above 60. Their risk of dying from other causes dwarfed their risk of needing dialysis by a factor of hundreds.5JAMA Internal Medicine. Accounting for Age in the Definition of Chronic Kidney Disease For a 70-to-74-year-old in that eGFR range, the risk of death was 122 times the risk of kidney failure. These findings fuel the argument that applying a rigid cutoff to older adults creates unnecessary diagnoses.

On the other side of the debate, researchers point out that a GFR of 45 to 59 in an older adult is not entirely benign either. Large epidemiological studies link that range to higher rates of cardiovascular events and death compared with peers whose GFR stays above 60, even when there’s no protein in the urine.6PubMed Central. Age-adapted versus age-independent eGFR thresholds to diagnose CKD: integrating the debate and charting a balanced path forward So while the risk of progressing to dialysis is low, the cardiovascular risk tied to reduced kidney function doesn’t vanish just because the decline is age-related. The practical takeaway: if you’re 70 and your eGFR reads 55 with no protein in your urine, your doctor should be watching the trend rather than panicking over the number.

Why Your eGFR Number Could Be Misleading

Most routine lab work estimates GFR from serum creatinine, a waste product generated by muscle metabolism. The calculation assumes a roughly average body composition for your age, sex, and (depending on the equation) race. The problem is that older adults often have less muscle mass than the assumptions baked into the formula, and creatinine production falls along with it. That means the creatinine level looks reassuringly low, and the eGFR comes back deceptively high.

Research using body-composition scans has quantified this effect: eGFR overestimates true kidney function by roughly 6 mL/min for every 10 kg of lean muscle mass a person is short of average.7EClinicalMedicine. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy That is not a trivial error. An older adult who has lost significant muscle, whether from sarcopenia, chronic illness, or simply being sedentary, could have a creatinine-based eGFR that reads 65 when their actual GFR is in the low 50s. The reverse is also true: an unusually muscular 70-year-old may get a falsely low reading.

The muscle-mass problem is not the same for men and women. Men tend to lose muscle more steeply with age than women do, which means their creatinine levels drop more over time relative to their starting point. This can mask declining kidney function in older men particularly.8Heliyon. Impact of age and sex on the relationship between muscle mass and serum creatinine levels in an apparently healthy population In older women, muscle mass tends to be more stable, but the baseline is lower, which introduces its own estimation quirks.

Cystatin C and the “Lower Number Wins” Rule

An alternative blood marker called cystatin C is produced by nearly all cells in the body at a relatively steady rate, so it doesn’t swing with muscle mass the way creatinine does.9PubMed Central. Kidney function in cachexia and sarcopenia: Facts and numbers When doctors order a cystatin C test alongside creatinine, they get two independent eGFR estimates. If the two agree, confidence is high. If they diverge, the question becomes which one to trust.

A study of over 650 older adults from the Berlin Initiative Study measured actual GFR using an injected tracer (the gold standard) and compared it with both creatinine-based and cystatin C-based estimates. The consistent finding was that whichever of the two eGFR values was lower tended to be closer to the true, measured GFR about 76% of the time.10Nephrology Dialysis Transplantation. MO373: How to Decide Whether Creatinine or Cystatin C is More Accurate for Kidney Function Assessment in Older Adults A separate study in older adults confirmed this pattern: when the two estimates disagreed, the lower one generally showed less bias and higher accuracy against measured GFR.11PubMed Central. Estimated GFR Accuracy When Cystatin C– and Creatinine-Based Estimates Are Discrepant in Older Adults

In practical terms, if your creatinine-based eGFR says 62 and a cystatin C-based eGFR says 51, the 51 is more likely to reflect reality. One study of elderly patients found that adding cystatin C reclassified over a third of cases to a more advanced CKD stage than creatinine alone had suggested.12PubMed Central. Questionable Validity of Creatinine-Based eGFR in Elderly Patients but Cystatin C Is Helpful in First-Line Diagnostics If you’re 70 and your doctor has only ever checked creatinine, asking about a cystatin C test is reasonable, especially if you’ve lost weight, have low muscle mass, or your creatinine-based eGFR seems surprisingly good for how you feel.

What Actually Predicts Trouble

A single eGFR number is a snapshot, and snapshots can be misleading. What matters far more at 70 is the trajectory: is the number stable year over year, or is it sliding? A person whose eGFR hovers between 55 and 60 over five years is in a very different position from someone whose eGFR dropped from 70 to 50 in the same window. The second pattern suggests something beyond normal aging is at play, whether it’s poorly controlled blood pressure, diabetes, repeated kidney injuries, or another process.

Protein in the urine, measured as the albumin-to-creatinine ratio (ACR), is the other major signal. Among older adults with diabetes, having both a low GFR and elevated urine albumin independently and additively increased the risk of dying, with each factor roughly doubling the hazard on its own and the combination being worse than either alone.13PubMed Central. Cystatin C, albuminuria, and mortality among older adults with diabetes A 70-year-old with an eGFR of 55 and no albumin in the urine is in a fundamentally different risk category from one with the same eGFR and a urine ACR of 60 mg/g.

Separately, a study following people from age 70 found that those with moderate kidney insufficiency at baseline had a twelve-year mortality rate of about 39%, compared with 27% in those with better kidney function, and that survival difference was apparent within just three years.14QJM: An International Journal of Medicine. Moderate renal insufficiency at 70 years predicts mortality The excess risk persisted after adjusting for common risk factors. So while an eGFR of 55 with no urine protein doesn’t mean you need dialysis anytime soon, it is still a marker your doctor should take seriously for cardiovascular risk management.

Factors That Speed Up Kidney Decline

Among the conditions that push GFR downward faster than aging alone, diabetes and high blood pressure dominate. In a study of over 1,600 people with type 2 diabetes, those whose kidney function was declining rapidly were on average several years older than stable patients, and age was an independent predictor of the speed of eGFR decline even after accounting for other factors.15PubMed Central. Chronic Kidney Disease and Progression: Risk factors for rapid kidney function decline in diabetes patients In other words, being older and having diabetes compounds the risk in a way that neither factor alone fully explains.

The kidney’s vulnerability to acute injury also increases with age. When an older person’s creatinine rises sharply due to dehydration, a medication reaction, or a contrast dye used in imaging, the percentage drop in eGFR can be steeper than in a younger person with the same percentage rise in creatinine, especially in women with already reduced baseline function. This heightened sensitivity means that events often brushed off as minor in younger adults, like a few days of not drinking enough water during a stomach bug, can produce measurable kidney damage in a 70-year-old.

One factor that turns out to be less important than many people assume is dietary protein. A large study following older adults over several years found no significant association between protein intake and the rate of eGFR decline, regardless of whether the protein came from animal or plant sources. About 27% of participants experienced rapid kidney decline, but protein intake did not predict who ended up in that group.16PubMed Central. Dietary Protein Intake and Change in Estimated GFR in the Cardiovascular Health Study This doesn’t mean protein intake never matters, particularly in someone already below an eGFR of 30, where more restrictive dietary guidance may apply. But for a 70-year-old with a GFR in the 50s or 60s, the popular advice to “eat less protein to save your kidneys” is not well supported by the evidence.

Medications and Dose Adjustments

Even if a lower eGFR at 70 isn’t clinically alarming, it has practical consequences. Dozens of commonly prescribed drugs, from certain antibiotics and pain relievers to diabetes medications and blood thinners, are cleared through the kidneys and require dose adjustments once eGFR drops below specific thresholds, often 60, 45, or 30. This is one of the strongest arguments for knowing your eGFR accurately even if it doesn’t qualify you for a CKD diagnosis: an overestimated number could lead to a drug dose that’s too high for your actual kidney function.

The muscle-mass problem discussed earlier becomes especially relevant here. If your creatinine-based eGFR reads 63 but your true GFR is closer to 50 because you’ve lost significant muscle, you might be getting the full dose of a medication that should have been reduced. Getting a cystatin C measurement or at least flagging your body composition to your prescriber can prevent this kind of dosing error.

Common over-the-counter medications deserve attention too. Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen reduce blood flow to the kidneys and can push a borderline GFR lower, sometimes acutely. At 70, even a short course taken alongside a blood-pressure medication can be enough to cause a noticeable dip. Doctors often advise older adults with reduced GFR to use acetaminophen instead for routine pain relief, though that carries its own considerations at high doses.

How Often Should GFR Be Checked

If you’re 70 with a stable eGFR in the 55-to-70 range and no protein in your urine, annual blood work is typically sufficient to monitor the trend. A steeper pattern, say losing more than 5 mL/min per year, warrants closer attention and possibly referral to a nephrologist. The same goes for a sudden drop in eGFR between tests, which may signal an acute injury rather than chronic decline.

Urine albumin testing is underused in older adults. It’s a simple test, usually done on a single urine sample, and it provides information that eGFR alone cannot. Two people with identical eGFRs can have vastly different outlooks depending on whether their kidneys are leaking protein. If your doctor checks your eGFR but never tests your urine, it’s worth asking about it, particularly if you have diabetes or high blood pressure.

The Fibrosis-Senescence Cycle in Aging Kidneys

Research over the past decade has clarified why some kidneys age gracefully while others spiral. At the cellular level, aging kidney cells enter a state called senescence, where they stop dividing but remain metabolically active, pumping out inflammatory signals that encourage scarring. That scarring, in turn, pushes more cells into senescence, creating a self-reinforcing loop. This fibrosis-senescence axis is now recognized as a shared feature of kidney aging, acute kidney injury, and chronic kidney disease, which helps explain why a single episode of acute injury in an older person can accelerate long-term decline: it supercharges a cycle that was already ticking along in the background.17Pharmacological Reviews. Renal aging and associated diseases: Common mechanisms and therapeutic approaches

Understanding this loop has practical implications beyond the biology. It means that preventing acute kidney injuries, keeping blood pressure controlled, and avoiding nephrotoxic drugs may do more to preserve kidney function in a 70-year-old than any single intervention aimed at the GFR number itself. The number is downstream of the biology; the biology responds best to upstream prevention.